Silver Nanoparticles as Potential Antiviral Agents

Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Cantisani, Marco; Marra, Veronica; Galdiero, Massimiliano
October 2011
Molecules;Oct2011, Vol. 16 Issue 10, p8894
Academic Journal
Virus infections pose significant global health challenges, especially in view of the fact that the emergence of resistant viral strains and the adverse side effects associated with prolonged use continue to slow down the application of effective antiviral therapies. This makes imperative the need for the development of safe and potent alternatives to conventional antiviral drugs. In the present scenario, nanoscale materials have emerged as novel antiviral agents for the possibilities offered by their unique chemical and physical properties. Silver nanoparticles have mainly been studied for their antimicrobial potential against bacteria, but have also proven to be active against several types of viruses including human imunodeficiency virus, hepatitis B virus, herpes simplex virus, respiratory syncytial virus, and monkey pox virus. The use of metal nanoparticles provides an interesting opportunity for novel antiviral therapies. Since metals may attack a broad range of targets in the virus there is a lower possibility to develop resistance as compared to conventional antivirals. The present review focuses on the development of methods for the production of silver nanoparticles and on their use as antiviral therapeutics against pathogenic viruses.


Related Articles

  • Tkm-ebola.  // Reactions Weekly;Sep2015, Vol. 1567 Issue 1, p200 

    The article presents case reports of two patients who developed fever and a deterioration Ebola virus disease (EVD) during therapy with Tkm-ebola. One patient who had been diagnosed with EVD, received Tkm-ebola infusion and subsequently received the infusion. The second patient, who had been...

  • antiviral drugs. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p60 

    An encyclopedia entry for "antiviral drugs" is presented. They refer to drugs used to treat viral infections. These drugs can decrease the severity of some viral infections, particularly in people who have reduced immunity. Most of them work by disrupting the chemical processes necessary for the...

  • Sustained and transient oscillations and chaos induced by delayed antiviral immune response in an immunosuppressive infection model. Shu, Hongying; Wang, Lin; Watmough, James // Journal of Mathematical Biology;Jan2014, Vol. 68 Issue 1/2, p477 

    Sustained and transient oscillations are frequently observed in clinical data for immune responses in viral infections such as human immunodeficiency virus, hepatitis B virus, and hepatitis C virus. To account for these oscillations, we incorporate the time lag needed for the expansion of immune...

  • Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Xiaoyan Cui; Yueling Wang; Kokudo, Norihiro; Dingzhi Fang; Wei Tang // BioScience Trends;Apr2010, Vol. 4 Issue 2, p39 

    Hepatitis B induced by hepatitis B virus (HBV) remains a major public health problem worldwide. Although several antiviral drugs have been approved for hepatitis B, they cause significant dose-dependent side-effects (interferon-α) and drug resistance (lamivudine, etc.). Safe and potent new...

  • Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B... Dore, Gregory J.; Cooper, David A.; Barrett, Catherine; Li-Ean Goh; Thakrar, Bharat; Atkins, Mark // Journal of Infectious Diseases;9/1/99, Vol. 180 Issue 3, p607 

    Examines the efficacy and safety of lamivudine in persons coinfected with HIV type 1 and hepatitis B virus (HBV) using a coinfected persons in a randomized, controlled study. Drugs added to lamivudine under the treatment process used in the study; Effect of coinfection with HIV type 1 on HBV...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Apr2005, Vol. 19 Issue 4, p272 

    This article presents news related to antiviral agents. Patients receiving the fusion inhibitor enfuvirtide continue to derive clinical and immunological benefit from the drug even when viremia persists. Spanish researchers in Madrid found that, during treatment with the fusion inhibitor,...

  • A Brief Update on the AIDS Epidemic. Kopansky-Giles, Deborah // Journal of the American Chiropractic Association;Dec2004, Vol. 41 Issue 12, p40 

    Presents a brief update on the AIDS epidemic. Approximation made by the Joint United Nations Program on HIV/AIDS on the number of people who were infected with HIV by December 2003; Success of the Highly Active Antiretroviral Therapy in reducing viral load in people living with AIDS; Role played...

  • cidofovir.  // Royal Society of Medicine: Medicines;2002, p154 

    The article provides information on the drug cidofovir. It is an antiviral drug used in the treatment of life-threatening or sight-threatening cytomegalovirus retinitis infections in AIDS patients. It can be given with the drug probenecid to prolong its action. Administration is by intravenous...

  • TERAPIA ANTIVIRALÄ‚ ÃŽN INFECÅ¢IILE CU HERPESVIRUSURI ÃŽN PRACTICA PEDIATRICÄ‚. Popescu, Valeriu // Romanian Journal of Pediatrics;2007, Vol. 56 Issue 2, p124 

    The increase in the number and classes of antiviral agents that has occurred since the 1980s is remarkable. Antiviral drugs are currently available for the treatment of herpesvirus infections (herpes simplex virus - HSV, varicella-zoster virus - VZV, cytomegalovirus - CMV). This article...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics